SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : UROLOGIX (ULGX)--The next big thing! -- Ignore unavailable to you. Want to Upgrade?


To: Patrick A. Kelly who wrote (51)2/13/1998 8:31:00 AM
From: Ardee  Respond to of 73
 
To all,

It has always been my understanding that these sort of problems are inherent to the industry. If the suitor prevails (which is not yet the case with Ulgx) it is usually in everyone's best interest to strike a deal.

ARDEE



To: Patrick A. Kelly who wrote (51)3/13/1998 11:49:00 AM
From: Mel Spivak  Read Replies (1) | Respond to of 73
 
This ILGX "disater" is getting worse. They announce a slowdown, stock is now downgraded. HOWEVER, ULGX does not talk about the most important thing of all ... the very real possibility that, as the court has found, they violated their license of the patent and they, therefore are "Up the creek".

Say it ain't so, ULGX, I challenge you. I should have not only sold at a loss (got out around 16) but shorted at the same time.